GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
ALDH3A1 | 405 | LTM | Skin Cancer | NA | WM266-4 | NA | Western Blotting followed by RT-PCR and SFA | NA | 0.48 | 0.0074 | 31817719
|
KLF4 | 6348 | LTM | Skin Cancer | NA | WM266-4 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.0891 | 31817719
|
NANOG | 20857 | LTM | Skin Cancer | NA | WM266-4 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 31817719
|
NANOG | 20857 | LTM | Skin Cancer | NA | WM266-4 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.5461 | 26554153
|
POU5F1 | 9221 | LTM | Skin Cancer | NA | WM266-4 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 31817719
|
POU5F1 | 9221 | LTM | Skin Cancer | NA | WM266-4 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.6448 | 26554153
|
PROM1 | 9454 | LTM | Skin Cancer | NA | WM266-4 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.7582 | 31817719
|
PROM1 | 9454 | LTM | Skin Cancer | NA | WM266-4 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.7582 | 26554153
|
SOX2 | 11195 | LTM | Skin Cancer | NA | WM266-4 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 31817719
|
MS4A1 | 7315 | LTM | Skin Cancer | NA | WM266-4 | NA | SFA followed by FACs and RT-PCR | NA | 0.32 | 0.0085 | 26554153
|
BMI1 | 1066 | LTM | Skin Cancer | NA | WM266-4 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.1135 | 26554153
|
MYC | 7553 | LTM | Skin Cancer | NA | WM266-4 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.1304 | 26554153
|